Minna Valkonen-Korhonen1,2, Hanna Leinola1, Mervi Könönen2,3, Eini Niskanen4, Maija Purhonen1,2, Maarit Pakarinen1,2, Anu Ruusunen1,2,5, Soili M Lehto1,2,6, Esa Mervaala2,3,7, Kirsi Honkalampi8, Heli Koivumaa-Honkanen1,2,9,10,11,12, Heimo Viinamäki1,2. 1. a Department of Psychiatry , Kuopio University Hospital , Kuopio , Finland. 2. b Institute of Clinical Medicine/Psychiatry , University of Eastern Finland , Kuopio , Finland. 3. c Department of Clinical Neurophysiology , Kuopio University Hospital , Kuopio , Finland. 4. d Department of Applied Physics , University of Eastern Finland , Kuopio , Finland. 5. e Food and Mood Centre/IMPACT SRC School of Medicine , Deakin University , Geelong , Australia. 6. f Department of Psychology and Logopedics Faculty of Medicine , University of Helsinki , Helsinki , Finland. 7. g Institute of Clinical Medicine/Clinical Neurophysiology , University of Eastern Finland , Kuopio , Finland. 8. h School of Educational Sciences and Psychology , University of Eastern Finland , Joensuu , Finland. 9. i Departments of Psychiatry: North Karelia Central Hospital , Joensuu , Finland. 10. j SOTE , Iisalmi , Finland. 11. k South-Savonia Hospital District , Mikkeli , Finland. 12. l Lapland Hospital District , Rovaniemi , Finland.
Abstract
BACKGROUND AND AIM: Prevention of the recurrence of major depression and its residual symptoms requires effective treatment. Our aim was to study the effects of bifrontal active rTMS controlled by sham rTMS in treatment-resistant unipolar major depressive disorder (MDD). METHODS:Thirty-seven patients with treatment-resistant MDD were randomized into two groups. One group received a total of 30 sessions of active bifrontal rTMS (10 Hz rTMS on left dorsolateral prefrontal cortex (DLPFC) and 1 Hz rTMS on right DLPFC) and the other group received bilateral sham rTMS on five days a week for six weeks. RESULTS:Depressive symptoms significantly improved in both the groups, but without a significant group difference. Furthermore, patients with psychotic depression improved similarly to those with moderate or severe depression. CONCLUSIONS: The results of present study indicate a large sham effect of stimulation treatment. The intensive structured treatment protocol may explain the positive outcome in both the groups. It is important to recognize, appreciate, and utilize placebo effects as a significant means of rehabilitation in psychiatric care.
RCT Entities:
BACKGROUND AND AIM: Prevention of the recurrence of major depression and its residual symptoms requires effective treatment. Our aim was to study the effects of bifrontal active rTMS controlled by sham rTMS in treatment-resistant unipolar major depressive disorder (MDD). METHODS: Thirty-seven patients with treatment-resistant MDD were randomized into two groups. One group received a total of 30 sessions of active bifrontal rTMS (10 Hz rTMS on left dorsolateral prefrontal cortex (DLPFC) and 1 Hz rTMS on right DLPFC) and the other group received bilateral sham rTMS on five days a week for six weeks. RESULTS:Depressive symptoms significantly improved in both the groups, but without a significant group difference. Furthermore, patients with psychotic depression improved similarly to those with moderate or severe depression. CONCLUSIONS: The results of present study indicate a large sham effect of stimulation treatment. The intensive structured treatment protocol may explain the positive outcome in both the groups. It is important to recognize, appreciate, and utilize placebo effects as a significant means of rehabilitation in psychiatric care.
Entities:
Keywords:
Treatment resistance; major depression; placebo effect; rTMS; sham